Brain Tumor Center, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Cancer Biology & Genetics Program, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Nat Neurosci. 2019 Apr;22(4):545-555. doi: 10.1038/s41593-018-0333-8. Epub 2019 Feb 18.
The contribution of lineage identity and differentiation state to malignant transformation is controversial. We have previously shown that adult neural stem and early progenitor cells give origin to glioblastoma. Here we systematically assessed the tumor-initiating potential of adult neural populations at various stages of lineage progression. Cell type-specific tamoxifen-inducible Cre recombinase transgenes were used to target glioblastoma-relevant tumor suppressors Nf1, Trp53 and Pten in late-stage neuronal progenitors, neuroblasts and differentiated neurons. Mutant mice showed cellular and molecular defects demonstrating the impact of tumor suppressor loss, with mutant neurons being the most resistant to early changes associated with tumor development. However, we observed no evidence of glioma formation. These studies show that increasing lineage restriction is accompanied by decreasing susceptibility to malignant transformation, indicating a glioblastoma cell-of-origin hierarchy in which stem cells sit at the apex and differentiated cell types are least susceptible to tumorigenesis.
谱系身份和分化状态对恶性转化的贡献存在争议。我们之前已经表明,成体神经干细胞和早期祖细胞起源于胶质母细胞瘤。在这里,我们系统地评估了各种谱系进展阶段的成体神经群体的肿瘤起始潜能。细胞类型特异性他莫昔芬诱导型 Cre 重组酶转基因被用于在晚期神经元祖细胞、神经母细胞和分化神经元中靶向胶质母细胞瘤相关的肿瘤抑制因子 Nf1、Trp53 和 Pten。突变小鼠表现出细胞和分子缺陷,表明肿瘤抑制因子缺失的影响,突变神经元对与肿瘤发展相关的早期变化最具抵抗力。然而,我们没有观察到神经胶质瘤形成的证据。这些研究表明,谱系限制的增加伴随着恶性转化易感性的降低,这表明胶质母细胞瘤的细胞起源存在层次结构,其中干细胞位于顶端,分化细胞类型对肿瘤发生的敏感性最低。